Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 62 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
La Pharmacie de Saintes from Tubize, company number BE0834237315, closed financial year 2025 with a result of € -9,774 after tax. For that financial year La Pharmacie de Saintes recorded a gross margin of € 237,889 and equity of € 49,942. Compared with financial year 2024, the result moved from € 39,397 to € -9,774. The company made a loss. The buffer shrank hard: equity is 69 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 49,942
▼ 69% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -9,774
▼ still € 39,397 profit in 2024
Profit after tax over the fiscal year.
€ 126,556
▲ 5% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 31,342.
People and assets in 2025
3.8
▲ 0.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 210,773
▲ 45% vs 2024
€ 55,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 24,436
▼ 26% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 33,213
▼ 75% vs 2024
Loans from banks and other lenders, long and short.
€ 63,141
▲ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 38,866
▲ 38% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 245,265 | € 230,915 | € 230,404 | € 237,889 | ▲ 3% |
| Profit after taxes | € 32,170 | € 25,124 | € 39,397 | € -9,774 | ▼ € 49,171 |
| Equity | € 115,195 | € 140,319 | € 159,716 | € 49,942 | ▼ 69% |
| Total debts | € 439,802 | € 416,161 | € 395,657 | € 464,634 | ▲ 17% |
| Cash | € 98,497 | € 118,990 | € 120,039 | € 126,556 | ▲ 5% |
| Land & buildings | € 151,800 | € 133,400 | € 115,000 | € 96,600 | ▼ 16% |
| Retained profit | € 96,595 | € 121,719 | € 141,116 | € 31,342 | ▼ 78% |
| Dividend | € 0 | € 0 | € 20,000 | € 100,000 | ▲ € 80,000 |
| Bank debt | € 306,766 | € 216,330 | € 130,395 | € 33,213 | ▼ 75% |
| Balance sheet total | € 554,998 | € 556,480 | € 555,373 | € 514,575 | ▼ 7% |
| Employees (FTE) | 2.8 | 2.9 | 2.9 | 3.8 | ▲ 0.9 |
Key figures of La Pharmacie de Saintes, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to La Pharmacie de Saintes?
What happened at La Pharmacie de Saintes in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 9,774 (▼ € 49,171 vs 2024). Source: NBB ↗
- CAROLINE DE VRIESE became a director. NBB
- New establishment in Tubize. KBO
- Start of the company according to the CBE. KBO
- ADV PHARMA SRL became a director. NBB
In short
From € 32,170 profit in 2022 to € 9,774 loss in 2025.
Paid € 32,464 in corporate taxes since 2022.
Best year ever: 2024, with € 39,397 profit.
On average € 62,600 of value added per employee in 2025.
A new publication or filing at La Pharmacie de Saintes? We notify you, reason included.
Follow La Pharmacie de SaintesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ADV Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
La Pharmacie de SaintesBehind La Pharmacie de Saintes are ADV PHARMA SRL and CAROLINE DE VRIESE. The shares are held by ADV Pharma (100%).
Directors
According to the 2025 annual accounts
Manager · represented by ALINE DE VRIESE
Also active at: LA PHARMACIE DE VRIESE, MEDI - PREST, BAUPHAR
since 2011
CAROLINE DE VRIESE
Manager
Also active at: LA PHARMACIE DE VRIESE, MEDI - PREST, ADV Pharma, BAUPHAR
since 2016
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Chaussée d'Hondzocht 441
1480 Tubize
Chaussée d'Enghien 284
1480 Tubize
Active since 3 March 2011
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0834.237.315
- VAT number
- BE 0834.237.315
- Registered office
- Chaussée d'Hondzocht 441, 1480 Tubize
- Names & denominations
- La Pharmacie de Saintes
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 March 2011
- Peppol
- Active · Active since 10 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten